Showing results (561-570 of 1,343) with videos related to

Sort By:
Pageof 135
The Pharmacogenomics Journal|March 9, 2016
A potentially functional polymorphism in ABCG2 predicts clinical outcome of non-small cell lung cancer in a Chinese populationJ Sun, M Zhu, W Shen, et al.
The Pharmacogenomics Journal|August 12, 2015
AGXT and ERCC2 polymorphisms are associated with clinical outcome in metastatic colorectal cancer patients treated with 5-FU/oxaliplatinJ B Kjersem, M Thomsen, T Guren, et al.
The Pharmacogenomics Journal|July 13, 2016
Lithium-responsive genes and gene networks in bipolar disorder patient-derived lymphoblastoid cell linesM S Breen, C H White, T Shekhtman, et al.
The Pharmacogenomics Journal|July 13, 2016
Investigation of 7-dehydrocholesterol reductase pathway to elucidate off-target prenatal effects of pharmaceuticals: a systematic reviewM R Boland, N P Tatonetti
The Pharmacogenomics Journal|August 2, 2017
Imatinib-induced ophthalmological side-effects in GIST patients are associated with the variations of EGFR, SLC22A1, SLC22A5 and ABCB1H-B Qiu, W Zhuang, T Wu, et al.
The Pharmacogenomics Journal|June 1, 2016
Genetic epidemiology of pharmacogenetic variants in South East Asian Malays using whole-genome sequencesA Sivadas, M Z Salleh, L K Teh, et al.
The Pharmacogenomics Journal|June 9, 2016
High frequency of CYP2D6 ultrarapid metabolizers in Spain: controversy about their misclassification in worldwide population studiesM E G Naranjo, F de Andrés, A Delgado, et al.
The Pharmacogenomics Journal|June 9, 2016
Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and SwedenT I Verhoef, W K Redekop, S Langenskiold, et al.
The Pharmacogenomics Journal|June 1, 2016
Genetic variations in immunomodulatory pathways to predict survival in patients with locoregional gastric cancerY Sunakawa, S Cao, N B Volz, et al.
The Pharmacogenomics Journal|June 1, 2016
Influence of ABCB1 and ABCG2 polymorphisms on the antiemetic efficacy in patients with cancer receiving cisplatin-based chemotherapy: a TRIPLE pharmacogenomics studyD Tsuji, M Yokoi, K Suzuki, et al.
Pageof 135